SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-15-028958
Filing Date
2015-05-11
Accepted
2015-05-11 06:02:40
Documents
10
Period of Report
2015-06-16
Effectiveness Date
2015-05-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A v409461_def14a.htm DEF 14A 801231
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_prophaselabs.jpg GRAPHIC 46628
4 GRAPHIC sig_tedkarkus.jpg GRAPHIC 13295
5 GRAPHIC spacer.gif GRAPHIC 43
6 GRAPHIC v407651_appb-1.jpg GRAPHIC 482707
7 GRAPHIC v407651_appb-2.jpg GRAPHIC 569356
8 GRAPHIC v407651_appc.jpg GRAPHIC 454287
9 GRAPHIC v409461_proxy-1.jpg GRAPHIC 486859
10 GRAPHIC v409461_proxy-2.jpg GRAPHIC 317717
  Complete submission text file 0001144204-15-028958.txt   4070297
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21617 | Film No.: 15848750
SIC: 2834 Pharmaceutical Preparations